The ACIP Turning Point: A Rallying Cry For A New Era of Public Health. A Talk w Drs. Craig Spencer, Rachael Bedard & Michael Mina

Welcome to a new era for public health. In the wake of RFK Jr.’s ACIP committee making its first major change to America’s childhood vaccine schedule—ending the universal Hepatitis B birth dose—we break down what this means, and what it doesn’t. Much of the mainstream public-health world is sounding alarms, calling the move dangerous, unscientific, and the opening salvo in a broader campaign against childhood vaccines. So today we ask some tough questions: Is this a reckless break from science—or a reasonable correction? Is this really about one dose of one vaccine, or the future of the entire childhood schedule? And now that ACIP is in the driver’s seat, is traditional public health's doom messaging the right and only course of action? Or should they rally around a different strategy? To help us sort it out, we’re joined by our own “fantasy ACIP” panel: Dr. Michael Mina, Dr. Rachael Bedard, and Dr. Craig Spencer.Hosts:Brinda AdhikariTom JohnsonMaggie BartlettDr. Mark AbdelmalekGuests:Dr. Rachael Bedard is an internist, geriatrician, and palliative-care physician whose work focuses on health, human rights, and justice. She teaches, advocates, and writes, you’ll find her work in the New York Times, The New Yorker, and a popular substack called The Argument. Dr. Craig Spencer is an emergency medicine physician and an Associate Professor at Brown University School of Public Health. He focuses on frontline preparedness in the U.S. and around the world and has written for various news publications, including the Atlantic and the New York Times.Dr. Michael Mina is an epidemiologist and immunologist and physician. Over the course of his career, he’s been an associate professor at Harvard Medical School as well as the TH Chan School of Public Health. In the height of the pandemic, he led America’s Test to Treat program, which connected home testing to treatment options. Thanks for listening! If you like us, please leave a review, rate us, and please subscribe! Got questions? Comments? We'd love to hear from you! Email us at [email protected]